Common Variable Immunodeficiency (Q55982504)

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Infections in 252 patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Autoimmune manifestations in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Lymphoproliferative disease in antibody deficiency: a multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Unravelling the complexity of T cell abnormalities in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Defective maturation of dendritic cells in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Altered dendritic cell distribution in patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Deficient IL-12 and dendritic cell function in common variable immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Common variable immunodeficiency is associated with defective functions of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TLR9 activation is defective in common variable immune deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Vitamin a deficiency in patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Severe hypoleptinaemia associated with insulin resistance in patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Immune competence and switched memory B cells in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Common variable immunodeficiency: association between memory B cells and lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Memory B cells in common variable immunodeficiency: clinical associations and sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

The EUROclass trial: defining subgroups in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

ICOS deficiency in patients with common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Impaired germinal center formation and recall T-cell–dependent immune responses in mice lacking the costimulatory ligand B7-H2

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

An antibody-deficiency syndrome due to mutations in the CD19 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Role for Msh5 in the regulation of Ig class switch recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TACI is mutant in common variable immunodeficiency and IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TACI mutation in common variable immunodeficiency and IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Regulated expression of BAFF-binding receptors during human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Selective activation of TACI by syndecan-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Tracking CD40 signaling during germinal center development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

TACI and BAFF-R mediate isotype switching in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88

Exogenous leptin restores in vitro T cell proliferation and cytokine synthesis in patients with Common Variable Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819DBF88